Loading…
National Peroxide (BSE 544205)₹524.00−1.74%Commodity Chemicals
In the Mar 2026 quarter (standalone), National Peroxide reported sales of ₹85.36 Cr, up 16.2% from Mar 2025, and net profit of ₹7.91 Cr. For the year to Mar 2026, sales were ₹289 Cr and net profit ₹10.97 Cr.
Company filings, standalone accounts; latest reported quarter Mar 2026
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 79.21 | 81.47 | 83.30 | 87.73 | 73.69 | 76.74 | 61.92 | 73.49 | 66.47 | 68.06 | 68.85 | 85.36 |
| Expenses | 69.72 | 72.97 | 74.48 | 79.31 | 64.03 | 73.19 | 59.10 | 76.36 | 62.10 | 64.06 | 62.35 | 71.09 |
| Operating Profit | 10.13 | 9.05 | 9.44 | 9.04 | 10.23 | 4.13 | 3.24 | −2.36 | 4.83 | 4.51 | 7.00 | 14.90 |
| OPM % | 12.6% | 11.0% | 11.2% | 10.2% | 13.8% | 5.3% | 5.2% | −3.2% | 7.2% | 6.5% | 10.1% | 17.3% |
| Other Income | 1.24 | 2.27 | 1.26 | 0.44 | 1.93 | 2.21 | 0.38 | 0.00 | 2.04 | 1.67 | 0.33 | 1.39 |
| Interest | 0.51 | 0.49 | 0.48 | 0.46 | 0.45 | 0.41 | 0.39 | 0.38 | 0.35 | 0.34 | 0.31 | 0.31 |
| Depreciation | 4.73 | 4.82 | 4.82 | 4.85 | 4.85 | 4.97 | 5.18 | 5.07 | 5.12 | 5.17 | 5.20 | 5.27 |
| Profit before tax | 6.09 | 5.97 | 5.36 | 4.14 | 6.82 | 0.93 | −2.00 | −7.83 | 1.37 | 0.64 | 1.79 | 10.68 |
| Tax % | 25.8% | 25.7% | 10.9% | 25.8% | 25.5% | 26.1% | −24.0% | −16.9% | 34.6% | 39.7% | −2.8% | 25.8% |
| Exceptional items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | −0.99 | 0.00 |
| Net Profit | 4.51 | 4.42 | 4.76 | 3.06 | 5.07 | 0.67 | −1.51 | −6.47 | 0.88 | 0.38 | 1.82 | 7.91 |
| EPS (Rs) | — | 7.69 | 8.27 | 5.33 | 8.82 | 1.17 | −2.63 | −11.26 | 1.54 | 0.67 | 3.17 | 13.76 |
| Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|
| Sales | 376 | 332 | 286 | 289 | 289 |
| Expenses | 318 | 296 | 271 | 260 | 260 |
| Operating Profit | 60.06 | 38.05 | 16.04 | 31.04 | 31.24 |
| OPM % | 16.0% | 10.9% | 6.0% | 11.0% | 10.8% |
| Other Income | 21.06 | 5.01 | 3.01 | 5.01 | 5.43 |
| Interest | 6.97 | 1.99 | 1.99 | 0.99 | 1.31 |
| Depreciation | 19.98 | 18.96 | 19.99 | 20.96 | 20.76 |
| Profit before tax | 54.03 | 22.03 | −2.01 | 14.02 | 14.48 |
| Tax % | 26.1% | 22.1% | 8.1% | 24.1% | — |
| Exceptional items | 9.97 | 0.00 | −0.99 | 0.00 | −0.99 |
| Net Profit | 39.90 | 16.96 | −1.99 | 10.97 | 10.99 |
| EPS (Rs) | — | 29.15 | −3.91 | 19.15 | 19.14 |
| Dividend payout % | 0.0% | 43.0% | 0.0% | 36.0% | — |
| Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|
| Equity Capital | 0.00 | 5.99 | 5.99 | 6.00 |
| Reserves | 346 | 353 | 344 | 356 |
| Borrowings | 23.04 | 20.03 | 16.02 | 13.00 |
| Other Liabilities | 86.41 | 81.38 | 76.36 | 82.39 |
| Total Liabilities | 455 | 459 | 442 | 457 |
| Fixed Assets | 336 | 321 | 312 | 297 |
| CWIP | 2.99 | 10.96 | 2.99 | 2.99 |
| Investments | 40.15 | 35.16 | 37.16 | 51.23 |
| Other Assets | 77.21 | 92.13 | 90.17 | 106 |
| Inventories | 37.85 | 33.79 | 32.47 | 38.01 |
| Trade receivables | 24.31 | 27.23 | 22.86 | 25.64 |
| Cash & equivalents | 6.98 | 17.18 | 23.73 | 27.60 |
| Total Assets | 455 | 459 | 442 | 457 |
| Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|
| Cash from operating activity | 67.08 | 36.06 | 19.01 | 34.04 |
| Cash from investing activity | 24.94 | −17.97 | −1.99 | −22.96 |
| Cash from financing activity | −85.71 | −16.94 | −12.95 | −4.99 |
| Net cash flow | 6.01 | 1.99 | 4.01 | 5.99 |
| Capex | 6.01 | 15.01 | 5.01 | 3.99 |
| Free cash flow | 61.19 | 22.07 | 14.04 | 30.10 |
| CFO / OP % | 125.0% | 117.0% | 131.0% | 105.0% |
| Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|
| Debtor days | 23 | 30 | 29 | 32 |
| Inventory days | 76 | 77 | 80 | 105 |
| Days payable | 46 | 51 | 49 | 45 |
| Cash conversion cycle | 53 | 56 | 60 | 92 |
| Working capital days | 26 | 28 | 29 | 85 |
| ROCE % | — | 6.0% | 0.0% | 4.0% |
For the Mar 2026 quarter, National Peroxide reported sales of ₹85.36 Cr, up 16.2% year on year and net profit of ₹7.91 Cr. The operating margin was 17.3%.
National Peroxide's sales for the year to Mar 2026 were ₹289 Cr; over the last twelve months they were ₹289 Cr.
Net profit for the year to Mar 2026 was ₹10.97 Cr, and ₹10.99 Cr over the last twelve months. Earnings per share over the same trailing period were ₹19.14.
National Peroxide reported borrowings of ₹13 Cr at Mar 2026, against cash and equivalents of ₹27.60 Cr.
Cash from operations was ₹34.04 Cr in the year to Mar 2026; after capital spending, free cash flow was ₹30.10 Cr.